Skip to main content

Volume 16 Supplement 3

Sepsis 2012

Protective effects of FCGR2A polymorphism in invasive pneumococcal diseases

Background

Streptococcus pneumoniae is a major cause of pneumonia and meningitis. Several genetic polymorphisms have been described to explain differences in susceptibility and severity of encapsulated pathogen-related diseases. Among them, a functional FCGR2A polymorphism leading to amino acid change of histidine (H) to arginine (R) at position 131 appears to be a major candidate in adult invasive pneumococcal diseases (IPD). However, previous reports needed confirmation in a large well-defined population.

Methods

A prospective genetic association study in a 24-bed medical ICU of a tertiary teaching hospital over 7 years. Patients were retrospectively selected from two prospective cohorts generated between January 2001 and December 2008. All Caucasian subjects with proven IPD and hospitalized in the ICU were included. Cases of IPD were defined by the isolation of S. pneumoniae from a normally sterile site (blood, bronchoalveolar lavage, quantitative tracheal aspiration, cerebrospinal fluid (CSF)). DNA from all Caucasian patients with IPD (pneumonia and/or meningitis) was genotyped for the FcγRIIa-R/H131polymorphism.

Results

Two hundred and forty-three patients with proven IPD were enrolled, 202 (82%) with pneumonia and 55 (22%) with meningitis. Mean age was 61 years, mean SAPS2 was 50.4, one-half of the patients had bacteremia, 84% of the cohort was mechanically ventilated and the hospital mortality rate was 31%. In the IPD group, distribution of the FcγRIIa-R/H131 genotypes (H/H: 25%; H/R: 53%; RR: 22%) was comparable with the distribution in the Caucasian control group. Comparison of the FcγRIIa-R/R131 and the (FcγRIIa-R/H131 + FcγRIIa-H/H131) groups did not demonstrate any difference for age, SAPS2, origin of sepsis and other co-morbid conditions. However, the variant FcγRIIa-R/R131 genotype was independently associated with decreased hospital mortality (OR = 0.251, CI 0.098 to 0.645; P = 0.004). See Figure 1.

Figure 1
figure 1

Kaplan-Meier anlaysis of the probability of survival according to FcγRIIa polymorphism.

Conclusion

In a well-defined population of IPD patients, the frequency of the variant FcγRIIa-R131 does not differ from other critically ill patients. However, the FcγRIIa-R/R131 genotype was independently associated with increased survival regardless of the site of infection.

Author information

Authors and Affiliations

Authors

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Bouglé, A., Max, A., Mongardon, N. et al. Protective effects of FCGR2A polymorphism in invasive pneumococcal diseases. Crit Care 16 (Suppl 3), P9 (2012). https://doi.org/10.1186/cc11696

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/cc11696

Keywords

  • Meningitis
  • Hospital Mortality
  • Amino Acid Change
  • Streptococcus Pneumoniae
  • Genetic Association Study